Health

Randomized controlled trials are the gold standard for evaluating treatment efficacy, but effectiveness in the real-world may vary. One reason...

The U.S. spends $413 billion dollars each year on diabetes-related care, meaning that diabetic patients now account for one of...

By KIM BELLARD Last week the Federal Trade Commission (FTC) issued its final “click-to-cancel” rule, making it easier for consumers...

An antibody drug is only as good as its ability to connect to its target. Sometimes a mutation at the...

THCB Walk Oct 24, 2024 Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday October 24 at 1pm PST 4pm EST...

Twenty years ago this month, 21 of the industry’s leading EHR vendors came together to form what was then called...

Jump start Open Enrollment for 2025 coverage by previewing plans with personalized price estimates based on your estimated income and household...

Terns Pharmaceuticals is making headlines with promising early results from its experimental GLP-1 obesity drug, which led to a 5.5%...

By MIKE MAGEE Has America turned into an “Island of Musk?” He seems to be everywhere and nowhere at the...

An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare...